Retatrutide: Eli Lillys Triple-Agonist Weight Loss Injection Explained (May 2026 Update) Eli Lillys latest development, Retatrutide , is showing extraordinary potential as a groundbreaking treatment for obesity and metabolic health
10.1016/j.psyneuen.2012.11.009 18 EricsonM.LofE.StombergR.SoderpalmB
Deep Blue (University of Michigan)
[2] [3] There is limited research on berberine's effects during pregnancy or lactation, and women who are pregnant, planning pregnancy, or breastfeeding should consult their GP, midwife or pharmacist before using any berberine products
Among more than 100,000 overweight and obese women, they found that GLP-1 agonist use was associated with lower breast cancer incidence
1 Week 6 Weeks 8 Weeks Two months in